# InterAx Biotech

> AI-driven drug discovery process

Business model and tags: AI & machine learning, Pharma & life sciences, Has in-house R&D

## About InterAx Biotech

A spin-out of ETH Zurich and the Paul Scherrer Institute, this company uses AI and cell pathways modeling for efficient drug discovery targeting GPCRs

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 11–50 employees
- **Headquarters**: schlieren, zurich, Switzerland
- **Founded**: 2016
- **Revenue**: CHF 6.6M – CHF 52.3M (Tamtam estimate)
- **Website**: [interaxbiotech.com](https://interaxbiotech.com/)
- **LinkedIn**: [linkedin.com/company/interax-biotech](https://www.linkedin.com/company/interax-biotech)

## InterAx Biotech at a glance

InterAx Biotech is a company in the Biotechnology Research industry, headquartered in schlieren, zurich, Switzerland.

InterAx Biotech was founded in 2016.

InterAx Biotech has 11–50 employees.

InterAx Biotech's revenue is CHF 6.6M – CHF 52.3M (Tamtam estimate).

## Frequently asked questions about InterAx Biotech

### What is InterAx Biotech's revenue?

Tamtam estimates InterAx Biotech's annual revenue at CHF 6.6M – CHF 52.3M.

### How many employees does InterAx Biotech have?

InterAx Biotech has 11–50 employees.

### Where is InterAx Biotech headquartered?

InterAx Biotech is headquartered in schlieren, zurich, Switzerland.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/interax-biotech